Drug safety through drug legislation
Kimbel, K.H.
Der Internist 19(6): 326-332
1978
ISSN/ISBN: 0020-9554 PMID: 352981 Document Number: 125982
Document emailed within 1 workday
Related Documents
Pedersen, P.A. 1975: Drug legislation and drug evaluation. Important aspects discussed in West Germany Ugeskrift for Laeger 137(6): 333-335Schwabe, U. 1980: The influence of the drug legislation on drug information for the physician and patient Der Internist 21(6): 311-317
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Ecker-Schlipf, B. 1987: Disease and drug abuse. Current problems in drug safety Medizinische Monatsschrift für Pharmazeuten 10(8): 254-261
Leonard, B. 1987: Drug safety and drug toxicity: the Irish situation Irish Medical Journal 80(4): 106-107
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Feiden, K. 1975: New order in drug legislation Deutsche Medizinische Wochenschrift 100(17): 972-976
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Kopf, R. 1980: Drug legislation 1976: cost analysis for the pharmaceutical industry Der Internist 21(6): 333-338
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Gatty, B. 1994: Drug sampling: legislation proposed; industry receptive to ending practice Hospital Formulary 29(6): 478 477
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
DeCherney, G.S. 1998: The FDA and drug safety Delaware Medical Journal 70(9): 405-406
Oberpichler-Schwenk, H. 2009: Heparin - an example in drug safety Medizinische Monatsschrift für Pharmazeuten 32(1): 1
1988: The Veterinary Service Board. Animal drug legislation. Packaging and labelling of animal drugs Tijdschrift Voor Diergeneeskunde 113(18): 1031-1032
Karande, S.; Gogtay, N.J.; Kshirsagar, N.A. 2003: Improving drug safety monitoring Indian Pediatrics 40(12): 1167-1175
Scala, C.; Leone Roberti Maggiore, U.; Remorgida, V.; Venturini, P.L.; Ferrero, S. 2013: Drug safety evaluation of desogestrel Expert Opinion on Drug Safety 12(3): 433-444